Full Text View
Tabular View
No Study Results Posted
Related Studies
Joint Outcome Study Continuation for Children With Severe Factor VIII Deficiency (JOSC)
This study is enrolling participants by invitation only.
Study NCT01000844   Information provided by University of Colorado, Denver

First Received on October 22, 2009.   Last Updated on April 5, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hemophilia
Additional conditions recognized in this trial
Hemophilia A
More general conditions related to this trial
Blood Coagulation Disorders
Blood Coagulation Disorders, Inherited
Coagulation Protein Disorders
Genetic Diseases, Inborn
Hematologic Diseases
Hemorrhagic Disorders
Additional drug interventions recognized in this trial
Factor VIII
More general drug interventions related to this trial
Coagulants
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Colorado, Denver
Bayer
Rush University Medical Center
Phoenix Children's Hospital
The University of Texas Health Science Center, Houston
Oregon Health and Science University
Emory University
University of Texas Southwestern Medical Center
Brewer, Erin, PharmD
Indiana University School of Medicine
Intermountain Health Care, Inc.
Ann & Robert H Lurie Children's Hospital of Chicago


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services